Probiodrug's IPO

Probiodrug raised a round of funding on November 03, 2014. Investors include Public.

Probiodrug is dedicated to the discovery and development of small molecule drugs against novel molecular targets for the treatment of neuronal- and inflammatory diseases. The company develops therapeu…

Articles about Probiodrug's IPO: